ArticleMayo Clinic proceedings. Innovations, quality & outcomes2023
Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States.
Rafael Fonseca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.